MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2010198.pdf
Reference59 articles.
1. Bergers G, Graninger P, Braselmann S, Wrighton C, Busslinger M . (1995). Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol Cell Biol 15: 3748–3758.
2. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM et al. (2008). Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 25: 629–642.
3. Bock BC, Vacratsis PO, Qamirani E, Gallo KA . (2000). Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation. J Biol Chem 275: 14231–14241.
4. Brown PH, Alani R, Preis LH, Szabo E, Birrer MJ . (1993). Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8: 877–886.
5. Chadee DN, Kyriakis JM . (2004). MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nat Cell Biol 6: 770–776.
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis;Cancer Letters;2024-10
2. Molecular insights into the role of mixed lineage kinase 3 in cancer hallmarks;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
3. Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC;Journal of Medicinal Chemistry;2024-08-29
4. Design, synthesis of new 3H-imidazo[4,5-b]pyridine derivatives and evaluation of their inhibitory properties as mixed lineage kinase 3 inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-03
5. Suppressing the MLK3 promotes glutamine metabolism: mechanism and implications in progression of colon cancer;Journal of Men's Health;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3